MeritValue

Organon & Co.

OGNdata completeness 100%7 fiscal years on file
The thesis, from the filings

Organon & Co. earns about 15% on invested capital, but has diluted owners by 3% over 5 years — worth asking whether the growth reaches owners. The applicable estimate puts fair value near $35.17 a share. Whether it’s worth owning at today’s price is the last question — and yours to answer, below.

i. The business — what you’d actually own
FigureFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$6.3B1$6.17B2$6.26B3$6.4B3$6.22B3
Net income$1.35B4$917M5$1.02B6$864M6$187M6
Operating cash flow$2.16B7$858M8$799M9$939M9$700M9
Capital expenditure$192M10$196M11$251M12$175M12$162M12
Free cash flow (derived)$1.97B7,10$662M8,11$548M9,12$764M9,12$538M9,12
Total debt$9.13B13$8.91B14$8.76B15$8.88B16,17$8.64B16,17
Cash & equivalents$737M18$706M19$693M20$675M21$574M21
Diluted shares254.2M255.2M256.3M259.2M260.8M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom). A derived or summed figure cites every filing line it was built from.

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
$28.84
your share of equity
Profit it earned you last year
$7.17
Free cash flow it threw off
$20.63
Debt you’d be carrying
$331.49

10 shares is a claim on $28.84 of net worth that earned you $7.17 and generated $20.63 of cash last year, against $331.49 of debt.

iii. Is this a good business?
Moat signal · return on invested capital
15% avg · 5y
FY21 23%FY22 17%FY23 15%FY24 15%FY25 5%

It earned an average 15% on invested capital over 5 years. Compare that to what it costs to fund the business.

seeing a moat in the numbers →
Management signal · capital allocation
+3% shares · 5y

Share count is up 3% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has held roughly steady.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.6.0
DCF · Growth Exit 10Y
not applicable
negative equity value — refusing to publish per-share figure
assumptions (10)
  • Risk-free rate (10Y Treasury)5.00%
  • Equity risk premium5.00%
  • Beta (β)1.00
  • Equity share of capital85.0%
  • Debt spread over risk-free1.50%
  • Tax rate21.0%
  • Terminal growth2.50%
  • Projection period10 years
  • FCF growth0.0%
  • Starting free cash flow$548M
DCF · Growth Exit 5Y
not applicable
negative equity value — refusing to publish per-share figure
assumptions (10)
  • Risk-free rate (10Y Treasury)5.00%
  • Equity risk premium5.00%
  • Beta (β)1.00
  • Equity share of capital85.0%
  • Debt spread over risk-free1.50%
  • Tax rate21.0%
  • Terminal growth2.50%
  • Projection period5 years
  • FCF growth0.0%
  • Starting free cash flow$548M
Earnings Power Value
$35.17
assumptions (8)
  • Risk-free rate (10Y Treasury)5.00%
  • Equity risk premium5.00%
  • Beta (β)1.00
  • Equity share of capital85.0%
  • Debt spread over risk-free1.50%
  • Tax rate21.0%
  • Normalized earnings$917M
  • Growth assumed0.0%
Graham Number
$6.84
assumptions (1)
  • Graham multiplier (P/E × P/B)22.5×

Different models answer different questions — which to trust when →

Beyond this page

This page is free, and so is every other company on MeritValue.

In your AI assistant

Connect the MeritValue MCP server to Claude or another MCP client, ask about Organon & Co., and get these exact figures with their filing receipts — not an improvised DCF.

Get a free key →
Screen by model

Pull the companies with a published value under any model (up to 500 a request, filtered by data completeness) into your own sheet or agent. Screening is what Analyst adds, at $9/month.

See pricing →
On iPhone

Follow OGN and keep your own price beside the value. The same engine, with the same receipts.

MeritValue on the App Store →
Sources — the receipts
  1. 10-K filed 2024-02-26 · period ending 2021-12-31 · accession 0001628280-24-006733 (Revenues)
  2. 10-K/A filed 2025-11-10 · period ending 2022-12-31 · accession 0001104659-25-108693 (Revenues)
  3. 10-K filed 2026-02-24 · periods ending 2023-12-31, 2024-12-31, 2025-12-31 · accession 0001628280-26-011125 (Revenues)
  4. 10-K filed 2024-02-26 · period ending 2021-12-31 · accession 0001628280-24-006733 (NetIncomeLoss)
  5. 10-K/A filed 2025-11-10 · period ending 2022-12-31 · accession 0001104659-25-108693 (NetIncomeLoss)
  6. 10-K filed 2026-02-24 · periods ending 2023-12-31, 2024-12-31, 2025-12-31 · accession 0001628280-26-011125 (NetIncomeLoss)
  7. 10-K filed 2024-02-26 · period ending 2021-12-31 · accession 0001628280-24-006733 (NetCashProvidedByUsedInOperatingActivitiesContinuingOperations)
  8. 10-K/A filed 2025-11-10 · period ending 2022-12-31 · accession 0001104659-25-108693 (NetCashProvidedByUsedInOperatingActivities)
  9. 10-K filed 2026-02-24 · periods ending 2023-12-31, 2024-12-31, 2025-12-31 · accession 0001628280-26-011125 (NetCashProvidedByUsedInOperatingActivities)
  10. 10-K filed 2024-02-26 · period ending 2021-12-31 · accession 0001628280-24-006733 (PaymentsToAcquirePropertyPlantAndEquipment)
  11. 10-K/A filed 2025-11-10 · period ending 2022-12-31 · accession 0001104659-25-108693 (PaymentsToAcquirePropertyPlantAndEquipment)
  12. 10-K filed 2026-02-24 · periods ending 2023-12-31, 2024-12-31, 2025-12-31 · accession 0001628280-26-011125 (PaymentsToAcquirePropertyPlantAndEquipment)
  13. 10-K filed 2023-02-27 · period ending 2021-12-31 · accession 0001821825-23-000003 (LongTermDebt)
  14. 10-K filed 2024-02-26 · period ending 2022-12-31 · accession 0001628280-24-006733 (LongTermDebt)
  15. 10-K/A filed 2025-11-10 · period ending 2023-12-31 · accession 0001104659-25-108693 (LongTermDebt)
  16. 10-K filed 2026-02-24 · periods ending 2024-12-31, 2025-12-31 · accession 0001628280-26-011125 (LongTermDebtNoncurrent)
  17. 10-K filed 2026-02-24 · periods ending 2024-12-31, 2025-12-31 · accession 0001628280-26-011125 (DebtCurrent)
  18. 10-K filed 2023-02-27 · period ending 2021-12-31 · accession 0001821825-23-000003 (CashAndCashEquivalentsAtCarryingValue)
  19. 10-K filed 2024-02-26 · period ending 2022-12-31 · accession 0001628280-24-006733 (CashAndCashEquivalentsAtCarryingValue)
  20. 10-K/A filed 2025-11-10 · period ending 2023-12-31 · accession 0001104659-25-108693 (CashAndCashEquivalentsAtCarryingValue)
  21. 10-K filed 2026-02-24 · periods ending 2024-12-31, 2025-12-31 · accession 0001628280-26-011125 (CashAndCashEquivalentsAtCarryingValue)